Robert Barish, MD, MBA

Professor, Department of Emergency Medicine
Vice Chancellor for Health Affairs

Contact
914 S. Wood St., MC 973, Suite 101
Chicago, IL 60612

Publications

Education

MBA, Loyola University, 1995
MD, New York Medical College, 1979
BA, University of New Hampshire, 1975

Residency

Emergency Medicine, Georgetown University/George Washington University/MIEMSS, 1985
Medicine, Saint Vincent’s Hospital and Medical Center, 1983

Board Certifications

American Board of Emergency Medicine
American Board of Internal Medicine

Previously Funded Research

A Prospective Multicenter Dose-Ranging Study of Intra-Arterial Thrombolysis in Acute Middle Cerebral Artery Thrombolysis in Acute Middle Cerebral Artery Distribution Thromboembolic Stroke
Funded by Abbott Laboratories, 1996

Emergency Care Services/VAMC
Funded by Veterans Administration Agency No. V152P-3288, 1995

A Randomized Trial of an Invasive Versus Noninvasive Diagnostic Strategy in Evaluation of Emergency Department Patients with Acute Chest Pain
1994

Comparison of Intravenous D-Sotalol and Placebo in the Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm
Funded by Bristol-Myers Squibb, 1994

A Multicenter, Open-Label, Ascending-Dose, Safety and Tolerability Trial to Compare the Effects of CGP-39393 and Heparin When Given in Conjunction with Recombinant Tissue-Type Plasminogen Activator (rt-PA) to Patients with Acute Transmural Myocardial Infarction
Funded by Ciba-Geigy, 1992

Tissue Plasminogen Activator in Acute Ischemic Stroke
Funded by NIH- National Institute of Neurological Diseases and Stroke, 1991

A Randomized, Double-Blind, Multicenter Study Comparing Myocardial Function, Patency, and Safety of Intravenous Eminase (anistreplase; APSAC; BRL 26921) versus Intravenous Alteplase (t-PA) in Patients with an Acute Myocardial Infarction
Funded by Beecham, 1989 – 1990

An Evaluation of the Efficacy and Safety of Intravenous Nicardipine in Comparison to Placebo in the Treatment of Severe Hypertension With or Without End Organ Damage – A Double Blind, Randomized Multicenter Study
Funded by DuPont, 1987 – 1990

An Open Label Study Comparing the Efficacy of Oral Nifedipine vs. Parenteral Labetalol in the Management of Hypertensive Urgencies
Funded by Pfizer, 1987 – 1988

Immunotherapy of Disseminated Renal Cell Carcinoma with Recombinant Human Interleukin-2 (Ro 23-6019, rIL-2): A Phase II Study
1986 – 1988

Academic Interests

Emergency Medicine
Aerospace Medicine
Chest Pain Evaluation
Emergency Cardiology